[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 531)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.62,"TPM_sd":14.23,"TPM_min":0.9,"TPM_25th_percentile":4.23,"TPM_median":7.92,"TPM_75th_percentile":17.68,"TPM_max":100.26},{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 531)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":16.86,"TPM_sd":12.42,"TPM_min":2.2,"TPM_25th_percentile":6.36,"TPM_median":14.87,"TPM_75th_percentile":24.23,"TPM_max":58.32},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 181)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.98,"TPM_sd":8.21,"TPM_min":2.02,"TPM_25th_percentile":5.27,"TPM_median":8.42,"TPM_75th_percentile":14.33,"TPM_max":48.07},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 181)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":14.57,"TPM_sd":10.52,"TPM_min":2.68,"TPM_25th_percentile":7.7,"TPM_median":11.75,"TPM_75th_percentile":20.44,"TPM_max":61.16},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.91,"TPM_sd":2.82,"TPM_min":2.19,"TPM_25th_percentile":5.32,"TPM_median":6.73,"TPM_75th_percentile":8.12,"TPM_max":15.37},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.3,"TPM_sd":5.06,"TPM_min":1.73,"TPM_25th_percentile":2.83,"TPM_median":4.61,"TPM_75th_percentile":8.34,"TPM_max":15.05},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 12)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.58,"TPM_sd":14.7,"TPM_min":3.63,"TPM_25th_percentile":5.75,"TPM_median":7.89,"TPM_75th_percentile":13.2,"TPM_max":48.01},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 12)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.77,"TPM_sd":6,"TPM_min":5.54,"TPM_25th_percentile":8.07,"TPM_median":9.07,"TPM_75th_percentile":11.76,"TPM_max":19.41},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 35)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.27,"TPM_sd":4.27,"TPM_min":1.4,"TPM_25th_percentile":3.52,"TPM_median":6.4,"TPM_75th_percentile":9.06,"TPM_max":16.64},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 35)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.63,"TPM_sd":3.18,"TPM_min":2.7,"TPM_25th_percentile":6.12,"TPM_median":7.94,"TPM_75th_percentile":9.63,"TPM_max":11.28},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.31,"TPM_sd":10.45,"TPM_min":7.03,"TPM_25th_percentile":7.92,"TPM_median":8.64,"TPM_75th_percentile":14.02,"TPM_max":28.94},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.19,"TPM_sd":1.64,"TPM_min":4.44,"TPM_25th_percentile":4.71,"TPM_median":6.26,"TPM_75th_percentile":7.28,"TPM_max":8.34},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 70)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0003869","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.76,"TPM_sd":8.52,"TPM_min":0.7,"TPM_25th_percentile":5.96,"TPM_median":9.76,"TPM_75th_percentile":11.54,"TPM_max":56.58},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 70)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0003869","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.96,"TPM_sd":3.09,"TPM_min":3.13,"TPM_25th_percentile":4.79,"TPM_median":6.27,"TPM_75th_percentile":8.49,"TPM_max":13.98},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 24)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.48,"TPM_sd":4.53,"TPM_min":2.9,"TPM_25th_percentile":6.86,"TPM_median":8.95,"TPM_75th_percentile":10.27,"TPM_max":23.68},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 24)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.21,"TPM_sd":2.53,"TPM_min":4.23,"TPM_25th_percentile":7.37,"TPM_median":9.14,"TPM_75th_percentile":9.63,"TPM_max":10.68},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.57,"TPM_sd":0.84,"TPM_min":10.62,"TPM_25th_percentile":11.05,"TPM_median":11.56,"TPM_75th_percentile":12.08,"TPM_max":12.55},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.51,"TPM_sd":6.11,"TPM_min":8.57,"TPM_25th_percentile":10.1,"TPM_median":11.63,"TPM_75th_percentile":15.98,"TPM_max":20.34},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 88)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.72,"TPM_sd":2.11,"TPM_min":0.29,"TPM_25th_percentile":4.34,"TPM_median":5.27,"TPM_75th_percentile":7.42,"TPM_max":10.88},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 88)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.28,"TPM_sd":2.03,"TPM_min":3.03,"TPM_25th_percentile":5.22,"TPM_median":5.76,"TPM_75th_percentile":6.96,"TPM_max":11.22},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.09,"TPM_sd":3.98,"TPM_min":1.87,"TPM_25th_percentile":5.04,"TPM_median":7.58,"TPM_75th_percentile":9.44,"TPM_max":17.71},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.25,"TPM_sd":3.4,"TPM_min":2.47,"TPM_25th_percentile":5.26,"TPM_median":7.1,"TPM_75th_percentile":7.87,"TPM_max":13.02},{"x_label":"Glial-neuronal tumor NOS  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor NOS","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.65,"TPM_sd":3.52,"TPM_min":2.85,"TPM_25th_percentile":7.4,"TPM_median":8.89,"TPM_75th_percentile":11.06,"TPM_max":12.59},{"x_label":"Glial-neuronal tumor NOS  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor NOS","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.85,"TPM_sd":2.34,"TPM_min":4.6,"TPM_25th_percentile":5.64,"TPM_median":6.68,"TPM_75th_percentile":7.97,"TPM_max":9.27},{"x_label":"High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 112)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"High-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.19,"TPM_sd":8.28,"TPM_min":1.02,"TPM_25th_percentile":6.81,"TPM_median":9.5,"TPM_75th_percentile":14.66,"TPM_max":42.91},{"x_label":"High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 112)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"High-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.87,"TPM_sd":3.29,"TPM_min":3.44,"TPM_25th_percentile":5.34,"TPM_median":7.75,"TPM_75th_percentile":10.45,"TPM_max":16.03},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 234)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.89,"TPM_sd":3.24,"TPM_min":1.63,"TPM_25th_percentile":5.84,"TPM_median":7.59,"TPM_75th_percentile":9.69,"TPM_max":26.49},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 234)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.45,"TPM_sd":2.86,"TPM_min":1.11,"TPM_25th_percentile":5.55,"TPM_median":7.45,"TPM_75th_percentile":8.96,"TPM_max":16.13},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 118)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.17,"TPM_sd":5.45,"TPM_min":3.38,"TPM_25th_percentile":8.24,"TPM_median":11.41,"TPM_75th_percentile":15.36,"TPM_max":32.68},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 118)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.96,"TPM_sd":2.86,"TPM_min":5.64,"TPM_25th_percentile":7,"TPM_median":7.87,"TPM_75th_percentile":11.09,"TPM_max":13.63},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 21)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"Orphanet_2495","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.72,"TPM_sd":2.02,"TPM_min":2.4,"TPM_25th_percentile":4.43,"TPM_median":5.36,"TPM_75th_percentile":6.64,"TPM_max":10.17},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 21)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"Orphanet_2495","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.16,"TPM_sd":2.12,"TPM_min":0.18,"TPM_25th_percentile":3.72,"TPM_median":4.55,"TPM_75th_percentile":4.86,"TPM_max":7.22},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 357)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":25.48,"TPM_sd":13.43,"TPM_min":3.32,"TPM_25th_percentile":15.2,"TPM_median":22,"TPM_75th_percentile":34.68,"TPM_max":69.06},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 357)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.32,"TPM_sd":6.89,"TPM_min":2.32,"TPM_25th_percentile":9.68,"TPM_median":14.1,"TPM_75th_percentile":16.18,"TPM_max":23.67},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 157)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":15.93,"TPM_sd":6.69,"TPM_min":3.32,"TPM_25th_percentile":11.27,"TPM_median":15.1,"TPM_75th_percentile":20.03,"TPM_max":37.21},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 157)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":15.76,"TPM_sd":5.16,"TPM_min":9.47,"TPM_25th_percentile":12.67,"TPM_median":14.99,"TPM_75th_percentile":18.04,"TPM_max":23.67},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.53,"TPM_sd":1.74,"TPM_min":1.83,"TPM_25th_percentile":2.22,"TPM_median":2.91,"TPM_75th_percentile":4.41,"TPM_max":7.45},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.83,"TPM_sd":2.41,"TPM_min":0.93,"TPM_25th_percentile":2.31,"TPM_median":4.28,"TPM_75th_percentile":4.31,"TPM_max":7.3},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.67,"TPM_sd":6.46,"TPM_min":2.46,"TPM_25th_percentile":3.57,"TPM_median":8.3,"TPM_75th_percentile":13.4,"TPM_max":15.64},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.55,"TPM_sd":1.07,"TPM_min":0.37,"TPM_25th_percentile":1.1,"TPM_median":1.84,"TPM_75th_percentile":2.14,"TPM_max":2.45},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0019004","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":14.16,"TPM_sd":6.69,"TPM_min":3.1,"TPM_25th_percentile":9.25,"TPM_median":13.38,"TPM_75th_percentile":17.36,"TPM_max":38.96},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Relapse Tumors","Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0019004","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":17.37,"TPM_sd":7.01,"TPM_min":9.44,"TPM_25th_percentile":12.73,"TPM_median":17.5,"TPM_75th_percentile":19.39,"TPM_max":27.77}]